Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee.

Carter, Drew

Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee. [electronic resource] - Applied health economics and health policy Aug 2016 - 401-407 p. digital

Publication Type: Journal Article

1179-1896

10.1007/s40258-015-0220-3 doi


Advisory Committees
Australia
Cost-Benefit Analysis
Decision Making
Financing, Government
Health Policy--economics
Humans
Pharmaceutical Preparations--economics
Quality-Adjusted Life Years
Severity of Illness Index
Value-Based Purchasing